Skip to content
Search

Latest Stories

UK-India laser technology centre to benefit both countries' economies

LASER scientists and engineers from the UK and India will collaborate under a new innovation programme launched to develop fresh laser technologies that will have the potential to boost the economies of both countries.

Funded by UK Research and Innovation (UKRI), with the UK lead being the Science and Technology Facilities Council’s (STFC) Central Laser Facility (CLF), the £4 million Extreme Photonics Innovation Centre (EPIC) will be housed in laboratories set up at Tata Institute of Fundamental Research (TIFR) in Southern Indian city of Hyderabad.


The project will focus on developing and exploiting laser techniques for economic and societal impact.

The joint UK and India scheme will use particle and x-ray beams with the aim of revolutionising a range of areas of healthcare, such as high-resolution imaging, therapeutic, and biomedical applications to tackle health problems.

The EPIC project is one of 13 new research projects announced by the British Business Secretary Andrea Leadsom on Friday (10).

The funding for the projects will be matched by international collaborators from countries including India, China, the USA and Japan.

It brings the total UK investment in international scientific collaborations to more than £2 billion.

The investment in the EPIC project comes as part of the second wave of the Government’s Fund for International Collaboration, overseen by UKRI – the government’s research and development agency.

The UKRI will support EPIC and these other projects over a five-year period, helping to maintain the aim of promoting the UK as a world-class destination to generate and access research and innovation.

Professor V Chandrasekhar, Centre Director, TIFR Hyderabad said: “TIFR has a long tradition of research on lasers and plans to initiate new activities based on intense petawatt lasers at its Hyderabad campus. With this background, TIFR is collaborating with the CLF team to develop state of the art technologies that will be of great benefit to both India and UK.”

Speaking about EPIC the Central Laser Facility Director Professor John Collier said: “These new accelerators can deliver very bright particle and x-ray beams that could be used for high-resolution industrial and biomedical imaging, and for therapeutic applications.”

“CLF is a world-leader in exploiting these novel accelerators and we’ll build on our long-standing collaboration with the Tata Institute of Fundamental Research (TIFR) whose expertise in this area will help us develop this work further.”

EPIC’s UK Lead, Dr Rajeev Pattathil, said experiments using CLF’s existing high power laser systems had already demonstrated the potential application of the new accelerators in industry, engineering, science, medicine, and advanced materials.

“Working with India on developing further the technologies that transform novel accelerators to real-world applications will be mutually beneficial as India aspires to have a strong research programme in this area through the recently announced expansion of the TIFR centre in Hyderabad that will house EPIC,” he added.

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less